News US regulator grants $23 million to rare disease R&D FDA announces 21 rare disease clinical trial research grants.
News EU regulator recommends Intercept's potential liver blockbus... Sales forecast to reach $2.6 billion in 2020.
News Alnylam plunges after deaths in rare disease trial Biotech axes revusiran due to safety concerns.
News Faron moves ahead with "shock lung" drug Finnish firm eyes first drug for acute respiratory distress syndrome.
News US and EU regulators collaborate on rare diseases Clinical trial design among areas regulators will collaborate on
News Zafgen ends development of Prader-Willi drug Share price plummets after biotech said drug is unsafe.
Patients Prevention for a healthier, more productive society During Anthropy 2025: Rebooting Britain, web editor Nicole Raleigh spoke with David Gillen, chief medical officer at Norgine.
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
